1. Home >
  2. M&A >
  3. Divestiture >
  4. Croatia >
  5. Galapagos Acquires Fidelta

M&A Deal Summary

Galapagos Acquires Fidelta

On September 1, 2010, Galapagos acquired life science company Fidelta from GSK

Acquisition Highlights
  • This is Galapagos’ 5th transaction in the Life Science sector.
  • This is Galapagos’ 1st transaction in Croatia.
Investment Fate
  • Fidelta was divested to a consortium of strategic buyers in 2020 for 31M EUR.

M&A Deal Summary
Date 2010-09-01
Target Fidelta
Sector Life Science
Buyer(s) Galapagos
Sellers(s) GSK
Deal Type Divestiture

Target

Fidelta

Zagreb, Croatia
Fidelta Ltd. is a drug discovery service company with core scientific competencies in inflammation, fibrosis, and anti-infectives. The scope of services provided by Fidelta is complementary to Selvita’s offerings and will enable Selvita to build a competitive advantage in business areas such as DMPK, in vivo pharmacology, and toxicology, as well as increase its scale of operations within medicinal chemistry and in vitro pharmacology. Fidelta is based in Zagreb, Croatia.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Galapagos

Mechelen, Belgium
Category Company
Founded 1999
Sector Life Science
Employees683
Revenue 276M EUR (2024)
DESCRIPTION

Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines. Galapagos was incorporated in 1999 and is based in Mechelen, Belgium.

DEAL STATS #
Overall 5 of 9
Sector: Life Science M&A 5 of 8
Type: Divestiture M&A Deals 3 of 5
Country: Croatia M&A 1 of 2
Year: 2010 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-08-26 Sareum Holdings - Drug Discovery business

United Kingdom

Buy €695M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-07 GlaxoSmithKline - Medical Research Croatia

Zagreb, Croatia

GlaxoSmithKline - Medical Research Croatia provides discovery and development of medicines to treat human disease. The Zagreb centre comes with a strong heritage in the area of antibacterial research. The center is located in Zagreb, Croatia.

Buy -

Seller(S) 1

SELLER

GSK

Brentford, United Kingdom
Category Company
Founded 1715
Sector Life Science
Employees68,629
Revenue 31.4B GBP (2024)
DESCRIPTION
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.

GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.

DEAL STATS #
Overall 5 of 24
Sector: Life Science M&A 4 of 17
Type: Divestiture M&A Deals 5 of 23
Country: Croatia M&A 1 of 2
Year: 2010 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-06-30 GlaxoSmithKline - Medicines Research Centre

Verona, Italy

GlaxoSmithKline - Medicines Research Center is a global network of operations that provides a full suite of development services. The agreement also enhances Aptuit’s ability to serve customers working to develop compounds for high-value and strategically important therapeutic areas such as neurosciences discovery and development, as well as cardiovascular and infectious diseases.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-07 GlaxoSmithKline - Medical Research Croatia

Zagreb, Croatia

GlaxoSmithKline - Medical Research Croatia provides discovery and development of medicines to treat human disease. The Zagreb centre comes with a strong heritage in the area of antibacterial research. The center is located in Zagreb, Croatia.

Sell -
Mergr

Solution for

Product

Company

Legal